At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 66 enrolled
Drug / intervention
Ioforminol 160 mgI/mL +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 1/2, Open Label, Randomized Study of Low Concentration Ioforminol Injections for Use in Contrast-Enhanced Abdominal Computed Tomography in Healthy Volunteers
In Brief
A Phase 2 clinical trial evaluating Ioforminol 160 mgI/mL, Ioforminol 200 mgI/mL, and 1 other intervention for Healthy. Completed, enrolled 66 participants across 1 site.
Detailed Summary
To optimize both the Ioforminol concentration and dosage(s) for CECT of the abdomen. To evaluate the safety and tolerability of low concentration Ioforminol Injections. Study recruits healthy volunteers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
CollaboratorsPhysician Reference Laboratory, Quintiles, Inc.
Timeline
Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2012
Primary CompletionAug 2012
First PostedAug 2012
TodayJul 2026
First PostedAug 27, 2012
Enrollment StartJul 1, 2012
Primary CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 13.8 years ago
Interventions
Ioforminol 160 mgI/mLdrug
Given as s single administration to the subject
Ioforminol 200 mgI/mLdrug
Given as a single administration to the subject
Iopamidol 300 mgI/mLdrug
Given as a single administration to the subject